The transaction took place Aug. 10, at an average price of $1.56 a share.
With the acquisition, Mr. Flanagan now owns 1,431,814 shares of the company’s stock.
More articles on finance issues:
5 healthcare CFOs in the headlines
Ohio faces $558M loss in FY 2018 under proposed managed care organization tax change
CHS spin-off Quorum Health suffers heavy losses on impairment charges
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.